A.W. Sharfo

Erasmus MC Cancer Institute

Papers

1

Total Citations

34

H-Index

1

About

A.W. Sharfo is a leading figure in the automation of radiotherapy planning, with a particular focus on advancing robotic radiosurgery and stereotactic body radiation therapy (SBRT) for prostate cancer. Their most notable contribution is the development of the first fully automated planning solution for robotic radiosurgery, a breakthrough that demonstrated comparable or superior plan quality to automatically planned volumetric arc therapy (VMAT). This work, published in 2018 and garnering 34 citations, addressed a critical gap in the field, as prior automated systems were largely confined to conventional radiotherapy units. By enabling fully automated, clinically deliverable plans for robotic radiosurgery, Sharfo’s research has the potential to standardize treatment quality, reduce planning time, and improve patient outcomes. Their work is particularly impactful in the context of prostate SBRT, where precision and efficiency are paramount. Sharfo’s contributions are widely recognized, with their most-cited paper serving as a foundational reference for researchers and clinicians seeking to integrate automation into radiosurgery workflows. Their efforts continue to shape the future of automated radiotherapy, making high-quality, consistent treatment planning more accessible.

Research Focus

Key Achievements

1
H-Index
1
Papers
34
Total Citations
34
Avg Citations/Paper
🏆 Most Cited Paper
First fully automated planning solution for robotic radiosurgery – comparison with automatically planned volumetric arc therapy for prostate cancer
34 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Erasmus MC Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago